Lion Point Capital, LP Bridge Bio Pharma, Inc. Transaction History
Lion Point Capital, LP
- $12.9 Million
- Q4 2024
A detailed history of Lion Point Capital, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Lion Point Capital, LP holds 40,300 shares of BBIO stock, worth $1.46 Million. This represents 8.55% of its overall portfolio holdings.
Number of Shares
40,300
Previous 49,000
17.76%
Holding current value
$1.46 Million
Previous $1.25 Million
11.39%
% of portfolio
8.55%
Previous 3.35%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$916 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$911 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$547 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$451 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$224 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.37B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...